Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
Abstract During extracorporeal membrane oxygenation (ECMO), a delicate balance is required to titrate systemic anticoagulation to prevent thrombotic complications within the circuit and prevent bleeding in the patient. Despite focused efforts to achieve this balance, the frequency of both thrombotic...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-020-2726-9 |
id |
doaj-dcad27ce40f445f39dd9bd2c1047c4ed |
---|---|
record_format |
Article |
spelling |
doaj-dcad27ce40f445f39dd9bd2c1047c4ed2021-01-24T12:18:41ZengBMCCritical Care1364-85352020-01-0124111210.1186/s13054-020-2726-9Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMOMeghan M. Chlebowski0Sirine Baltagi1Mel Carlson2Jerrold H. Levy3Philip C. Spinella4Department of Pediatrics, Division of Pediatric Cardiology, Cardiovascular Intensive Care Unit, Cincinnati Children’s Hospital/University of Cincinnati College of MedicineDepartment of Pediatrics, Division of Critical Care Medicine, St. Joseph’s Children’s Hospital/University of Pittsburg School of MedicineLFB-USADepartment of Anesthesiology, Critical Care, and Surgery, Duke University School of MedicineDepartment of Pediatrics, Division of Pediatric Critical Care Medicine, Washington University School of MedicineAbstract During extracorporeal membrane oxygenation (ECMO), a delicate balance is required to titrate systemic anticoagulation to prevent thrombotic complications within the circuit and prevent bleeding in the patient. Despite focused efforts to achieve this balance, the frequency of both thrombotic and bleeding events remains high. Anticoagulation is complicated to manage in this population due to the complexities of the hemostatic system that are compounded by age-related developmental hemostatic changes, variable effects of the etiology of critical illness on hemostasis, and blood-circuit interaction. Lack of high-quality data to guide anticoagulation management in ECMO patients results in marked practice variability among centers. One aspect of anticoagulation therapy that is particularly challenging is the use of antithrombin (AT) supplementation for heparin resistance. This is especially controversial in the neonatal and pediatric population due to the baseline higher risk of bleeding in this cohort. The indication for AT supplementation is further compounded by the potential inaccuracy of the diagnosis of heparin resistance based on the standard laboratory parameters used to assess heparin effect. With concerns regarding the adverse impact of bleeding and thrombosis, clinicians and institutions are faced with making difficult, real-time decisions aimed at optimizing anticoagulation in this setting. In this clinically focused review, the authors discuss the complexities of anticoagulation monitoring and therapeutic intervention for patients on ECMO and examine the challenges surrounding AT supplementation given both the historical and current perspectives summarized in the literature on these topics.https://doi.org/10.1186/s13054-020-2726-9AnticoagulationAntithrombinExtracorporeal membrane oxygenation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Meghan M. Chlebowski Sirine Baltagi Mel Carlson Jerrold H. Levy Philip C. Spinella |
spellingShingle |
Meghan M. Chlebowski Sirine Baltagi Mel Carlson Jerrold H. Levy Philip C. Spinella Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO Critical Care Anticoagulation Antithrombin Extracorporeal membrane oxygenation |
author_facet |
Meghan M. Chlebowski Sirine Baltagi Mel Carlson Jerrold H. Levy Philip C. Spinella |
author_sort |
Meghan M. Chlebowski |
title |
Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO |
title_short |
Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO |
title_full |
Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO |
title_fullStr |
Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO |
title_full_unstemmed |
Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO |
title_sort |
clinical controversies in anticoagulation monitoring and antithrombin supplementation for ecmo |
publisher |
BMC |
series |
Critical Care |
issn |
1364-8535 |
publishDate |
2020-01-01 |
description |
Abstract During extracorporeal membrane oxygenation (ECMO), a delicate balance is required to titrate systemic anticoagulation to prevent thrombotic complications within the circuit and prevent bleeding in the patient. Despite focused efforts to achieve this balance, the frequency of both thrombotic and bleeding events remains high. Anticoagulation is complicated to manage in this population due to the complexities of the hemostatic system that are compounded by age-related developmental hemostatic changes, variable effects of the etiology of critical illness on hemostasis, and blood-circuit interaction. Lack of high-quality data to guide anticoagulation management in ECMO patients results in marked practice variability among centers. One aspect of anticoagulation therapy that is particularly challenging is the use of antithrombin (AT) supplementation for heparin resistance. This is especially controversial in the neonatal and pediatric population due to the baseline higher risk of bleeding in this cohort. The indication for AT supplementation is further compounded by the potential inaccuracy of the diagnosis of heparin resistance based on the standard laboratory parameters used to assess heparin effect. With concerns regarding the adverse impact of bleeding and thrombosis, clinicians and institutions are faced with making difficult, real-time decisions aimed at optimizing anticoagulation in this setting. In this clinically focused review, the authors discuss the complexities of anticoagulation monitoring and therapeutic intervention for patients on ECMO and examine the challenges surrounding AT supplementation given both the historical and current perspectives summarized in the literature on these topics. |
topic |
Anticoagulation Antithrombin Extracorporeal membrane oxygenation |
url |
https://doi.org/10.1186/s13054-020-2726-9 |
work_keys_str_mv |
AT meghanmchlebowski clinicalcontroversiesinanticoagulationmonitoringandantithrombinsupplementationforecmo AT sirinebaltagi clinicalcontroversiesinanticoagulationmonitoringandantithrombinsupplementationforecmo AT melcarlson clinicalcontroversiesinanticoagulationmonitoringandantithrombinsupplementationforecmo AT jerroldhlevy clinicalcontroversiesinanticoagulationmonitoringandantithrombinsupplementationforecmo AT philipcspinella clinicalcontroversiesinanticoagulationmonitoringandantithrombinsupplementationforecmo |
_version_ |
1724326065866801152 |